In the era of precision medicine, antibody-drug conjugates (ADCs) have emerged as a
cutting-edge therapeutic strategy. These innovative compounds combine the precision of …

Antibody-Drug Conjugates (ADCs) represent an innovative class of potent anti-cancer
compounds that are widely used in the treatment of hematologic malignancies and solid …

Clustered regularly interspaced short palindromic repeats (CRISPR) have established itself
as a frontier technology in genetic engineering. Researchers have successfully used the …

Background: Antibody-drug conjugate (ADC) is a promising therapy for solid cancer that has
raised global concern. Although several papers have reviewed the current state of ADCs in …

Opinion Statement Over the last several years, the treatment landscape of urothelial
carcinoma has witnessed an unprecedented expansion of therapeutic options including …

Targeted toxins (TT) for cancer treatment are a class of hybrid biologic comprised of a
targeting domain coupled chemically or genetically to a proteinaceous toxin payload. The …

Azo-dyes are widely used in cosmetic, textile, fibre, leather, printing and painting industries.
Besides their colouring function, azo compounds have been reported to have antibacterial …

Antibody–drug conjugates (ADCs) are formed by binding of cytotoxic drugs to monoclonal
antibodies (mAbs) through chemical linkers. A comprehensive evaluation of the critical …

Polyclonal immunoglobulin (Ig) preparations have been used for several decades for
treatment of primary and secondary immunodeficiencies and for treatment of some infections …

The present study focuses on the development and validation of an HPLC-DAD
methodology for the detection of a potent chemotherapeutic agent, Maytansinoid Ravtansine …